Avior Wealth Management LLC Buys 6,000 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Avior Wealth Management LLC raised its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 21.1% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 34,400 shares of the medical instruments supplier’s stock after purchasing an additional 6,000 shares during the quarter. Avior Wealth Management LLC’s holdings in DENTSPLY SIRONA were worth $653,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in XRAY. FMR LLC raised its holdings in DENTSPLY SIRONA by 5.1% during the 3rd quarter. FMR LLC now owns 9,056,774 shares of the medical instruments supplier’s stock valued at $245,076,000 after buying an additional 436,031 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in shares of DENTSPLY SIRONA by 50.4% during the third quarter. Charles Schwab Investment Management Inc. now owns 2,065,773 shares of the medical instruments supplier’s stock valued at $55,900,000 after acquiring an additional 692,100 shares during the last quarter. JPMorgan Chase & Co. grew its stake in shares of DENTSPLY SIRONA by 206.3% in the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier’s stock worth $49,990,000 after purchasing an additional 1,244,326 shares during the last quarter. National Bank of Canada FI increased its holdings in DENTSPLY SIRONA by 85.8% during the 3rd quarter. National Bank of Canada FI now owns 1,628,200 shares of the medical instruments supplier’s stock valued at $44,059,000 after purchasing an additional 751,800 shares during the period. Finally, Invenomic Capital Management LP bought a new position in DENTSPLY SIRONA during the 3rd quarter valued at approximately $23,724,000. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Performance

NASDAQ:XRAY opened at $19.53 on Friday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The stock has a 50-day simple moving average of $19.03 and a two-hundred day simple moving average of $22.67. The firm has a market capitalization of $3.88 billion, a PE ratio of -9.43, a P/E/G ratio of 1.80 and a beta of 0.96. DENTSPLY SIRONA Inc. has a 52-week low of $17.21 and a 52-week high of $35.68.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The company had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. During the same period in the previous year, the company posted $0.49 EPS. The firm’s revenue was up .4% on a year-over-year basis. Analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, January 10th. Investors of record on Friday, December 27th were issued a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 3.28%. The ex-dividend date of this dividend was Friday, December 27th. DENTSPLY SIRONA’s dividend payout ratio is currently -30.92%.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on XRAY. Jefferies Financial Group cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating and reduced their target price for the company from $30.00 to $20.00 in a research note on Thursday. Mizuho assumed coverage on shares of DENTSPLY SIRONA in a research report on Wednesday, December 4th. They set a “neutral” rating and a $21.00 price objective on the stock. UBS Group cut their target price on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a research note on Tuesday, December 3rd. StockNews.com downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Tuesday, November 19th. Finally, Leerink Partnrs cut DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Ten investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $26.67.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.